Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium
-
Published:2023-03
Issue:
Volume:19
Page:100445
-
ISSN:2667-193X
-
Container-title:The Lancet Regional Health - Americas
-
language:en
-
Short-container-title:The Lancet Regional Health - Americas
Author:
Choueiri Toni K., Labaki ChrisORCID, Bakouny Ziad, Hsu Chih-Yuan, Schmidt Andrew L., de Lima Lopes Gilberto, Hwang ClaraORCID, Singh Sunny R.K., Jani Chinmay, Weissmann Lisa B., Griffiths Elizabeth A., Halabi SusanORCID, Wu Ulysses, Berg Stephanie, O'Connor Timothy E., Wise-Draper Trisha M., Panagiotou Orestis A.ORCID, Klein Elizabeth J., Joshi Monika, Yared Fares, Dutra Miriam SantosORCID, Gatson Na Tosha N.ORCID, Blau Sibel, Singh Harpreet, Nanchal Rahul, McKay Rana R., Nonato Taylor K., Quinn Ryann, Rubinstein Samuel M., Puc Matthew, Mavromatis Blanche H., Vikas PraveenORCID, Faller Bryan, Zaren Howard A.ORCID, Del Prete Salvatore, Russell Karen, Reuben Daniel Y., Accordino Melissa K., Singh Harpreet, Friese Christopher R., Mishra SanjayORCID, Rivera Donna R., Shyr Yu, Farmakiotis Dimitrios, Warner Jeremy L.
Subject
Public Health, Environmental and Occupational Health,Internal Medicine,Health Policy
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|